2011
DOI: 10.1016/j.jss.2010.03.053
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of STAT3 Potentiates Growth, Survival, and Radioresistance of Non-Small-Cell Lung Cancer (NSCLC) cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
34
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(35 citation statements)
references
References 26 publications
1
34
0
Order By: Relevance
“…These cells have been commonly used as a model in the mechanistic studies of lung cancer radiosensitivity [7274], and they were cultured in RPMI-1640 medium with supplement of 10% fetal bovine serum (FBS, Gibco Invitrogen, Grand Island, NY, USA), 100 U/ml penicillin and 100 μg/ml streptomycin. All of the cells were cultured at 37°C in an atmosphere of 5% CO 2 .…”
Section: Methodsmentioning
confidence: 99%
“…These cells have been commonly used as a model in the mechanistic studies of lung cancer radiosensitivity [7274], and they were cultured in RPMI-1640 medium with supplement of 10% fetal bovine serum (FBS, Gibco Invitrogen, Grand Island, NY, USA), 100 U/ml penicillin and 100 μg/ml streptomycin. All of the cells were cultured at 37°C in an atmosphere of 5% CO 2 .…”
Section: Methodsmentioning
confidence: 99%
“…JAKs are well-known to activate STAT signaling, leading to regulation of the gene expression that influences processes associated with tumor malignancy including cell-cycle progression, angiogenesis, metastasis, and immune evasion (17,18). Many investigations have demonstrated that JAKs and STATs are highly activated in cases of lung cancer and implied that JAKs as upstream regulators can be promising targets for lung cancer therapy (19,20). For this, smallmolecule compounds targeting JAKs and their signaling activity have been currently developed as chemotherapeutic reagents.…”
Section: Introductionmentioning
confidence: 99%
“…It has been reported that overexpression of STAT3 is correlated with growth, survival, and radioresistance of NSCLC cells, and that STAT3 inhibition could inhibit tumorigenic ability and enhance the radiosensitivity of NSCLC cells both in vitro and in vivo (Yin et al, 2010;Hsu et al, 2011). Moreover, STAT3 polymorphisms have been shown to correlate with STAT3 expression and therapy response in certain malignancies (Ito et al, 2007;Kreil et al, 2010).…”
Section: Introductionmentioning
confidence: 99%